Cargando…
Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study
Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has proven efficacy and is recommended for major pediatric surgery to decrease perioperative blood loss. Accumulating evidence suggests that TXA reduces bleeding and transfusion in a variety of adult neurosurgical settings. However, there is...
Autores principales: | Wang, Jue T., Seshadri, Samir C., Butler, Carolyn G., Staffa, Steven J., Kordun, Anna S., Lukovits, Karina E., Goobie, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342645/ https://www.ncbi.nlm.nih.gov/pubmed/37445437 http://dx.doi.org/10.3390/jcm12134403 |
Ejemplares similares
-
Tranexamic acid in pediatric trauma: why not?
por: Beno, Suzanne, et al.
Publicado: (2014) -
Orbitopterional Craniotomy Resection of Pediatric Suprasellar Craniopharyngioma
por: LeFever, Devon, et al.
Publicado: (2018) -
Comparison of Tranexamic Acid with Aprotinin in pediatric cardiac surgery
por: Chauhan, Sandeep
Publicado: (2015) -
SURG-06. AWAKE CRANIOTOMY FOR BRAIN TUMOR IN PEDIATRIC PATIENTS
por: Almeida, Carlos, et al.
Publicado: (2020) -
Postoperative analgesia for pediatric craniotomy patients: a randomized controlled trial
por: Xing, Fei, et al.
Publicado: (2019)